David Armstrong is a senior reporter at ProPublica, specializing in health-care investigations. He joined ProPublica in March of 2018. Before that, he was a senior enterprise reporter for STAT, where he wrote about abuses in the addiction treatment industry, the rise of fentanyl, and the recruiting of college football players with histories of concussions.
In a sealed court document, one of the company's controlling members indicated that Purdue Pharma should not correct misconceptions about the strength of oxycodone.
The maker of the potent painkiller Oxycontin discussed how the sale of opioids and the treatment of opioid addiction were "naturally linked."
